Page 151 - Acrobat J Trad-21-3-2566

634 วารสารการแพทย์แผนไทยและการแพทย์ ทางเลือก ปีที่ 21 ฉบับที่ 3 กันยายน-ธันวาคม 2566

nolic and alkaloid extracts from Mitragyna speciosa mitragynine from Mitragyna speciosa Korth. Int J Health
(Rubiaceae family) leaves. Molecules. 2009;14(10):3964- Sci. 2022;6(S3):10254-61. https://doi.org/10.53730/ijhs.
74. https://doi.org/10.3390/molecules14103964. v6nS3.8448.
11. Limcharoen T, Pouyfung P, Ngamdokmai N, Prasopthum 19. Zhang P, Wei W, Zhang X, Wen C, Ovatlarnporn C,
A, Ahmad AR, Wisdawati W, Prugsakij W, Warinhom- Olatunji OJ. Antidiabetic and antioxidant activities
houn S. Inhibition of alpha-glucosidase and pancreatic of Mitragyna speciosa (kratom) leaf extract in type 2
lipase properties of Mitragyna speciosa (Korth.) Havil. diabetic rats. Biomed Pharmacother. 2023;162:114689.
(Kratom) leaves. Nutrients. 2022;14(19):3909. https://doi. http://doi.org/10.1016/j.biopha.2023.114689.
org/10.3390/ nu14193909. 20. León F, Habib E, Adkins JE, Furr EB, McCurdy CR,
12. Purintrapiban J, Keawpradub N, Kansenalak S, Chit- Cutler SJ. Phytochemical characterization of the leaves
trakarn S, Janchawee B, Sawangjaroen K. Study on of Mitragyna speciosa grown in U.S.A. Nat Prod Com-
glucose transport in muscle cells by extracts from mun. 2009;4(7):907-10.
Mitragyna speciosa (Korth) and mitragynine. Nat 21. Kamble SH, Sharma A, King TI, León F, McCurdy CR,
Prod Res. 2011;25(15):1379-87. https://doi.org/10.1080/ Avery BA. Metabolite profiling and identification of
14786410802267627. enzymes responsible for the metabolism of mitragynine,
13. Mossadeq WMS. Sulaiman MR, Mohamad TAT, Chi- the major alkaloid of Mitragyna speciosa (kratom).
ong HS, Zakaria ZA, Jabit ML, Baharuldin MTH, Israf Xenobiotica. 2019;49(11):1279-88. https://doi.org/
DA. Anti-Inflammatory and antinociceptive effects of 10.1080/00498254.2018.1552819.
Mitragyna speciosa Korth methanolic extract. Med Princ 22. Gowri PM, Tiwari AK, Ali AZ, Rao JM. Inhibition of
Pract. 2009;18:378–84. http://doi.org/10.1159/000226292. alpha-glucosidase and amylase by bartogenic acid iso-
14. Müller E, Hillemacher T, Müller CP. Kratom use for lated from Barringtonia racemosa Roxb. seeds. Phytother
depression/anxiety self-management: challenges dur- Res. 2007;21(8):796-9.
ing the COVID-19 pandemic - A case report. Heliyon. 23. Ademiluyi AO, Oboh G. Soybean phenolic-rich extracts
2021;7(5):e07039. https://doi.org/10.1016/j.heliyon.2021. inhibit key-enzymes linked to type 2 diabetes (alpha-
e07039. amylase and alpha-glucosidase) and hypertension
15. Buckhalter S, Soubeyrand E, Ferrone SAE, Rasmussen (angiotensin I converting enzyme) in vitro. Exp Toxicol
DJ, Manduca JD, Al-Abdul-Wahid MS, Frie JA, Khokhar Pathol. 2013;65(3):305-9.
JY, Akhtar TA, Perreault ML. The antidepressant-like 24. Lahogue V, Réhel K, Taupin L, Haras D, Allaume P. A
and analgesic effects of Kratom alkaloids are accompa- HPLC-UV method for the determination of angiotensin
nied by changes in low frequency oscillations but not I-converting enzyme (ACE) inhibitory activity. Food
ΔFosB accumulation. Front Pharmacol. 2021;12:696461. Chem. 2010;118(3);870-5.
https://doi.org/10.3389/fphar.2021.696461. 25. Ellman GL, Courtney KD, Andres V, Feather-stone RM. A
16. Goh TB, Koh RY, Mordi MN, Mansor SM. Antioxidant new and rapid colorimetric determination of acetylcho-
value and antiproliferative efficacy of mitragynine and linesterase activity. Biochem Pharmacol. 1961;7(2):91-5.
a silane reduced analogue. Asian Pac J Cancer Prev. 26. Pohanka M, Jun D, Kuca K. Photometric microplates
2014;15(14):5659-65. assay for estimation of the efficacy of paraoxon inhibited
17. Innok W, Hiranrat A, Chana N, Rungrotmongkol T, acetylcholinesterase reactivation. J. Enzyme Inhib Med
Kongsune P. In silico and in vitro anti-AChE activity Chem. 2008;23:781–4.
investigations of constituents from Mytragyna speciosa 27. Sharma A, Kamble SH, León F, Chear NJ, King TI,
for Alzheimer’s disease treatment. J Comput. Aided Mol. Berthold EC, Ramanathan S, McCurdy CR, Avery BA. Si-
Des. 2021;35:325–36. https://doi.org/10.1007/s10822-020- multaneous quantification of ten key Kratom alkaloids in
00372-4. Mitragyna speciosa leaf extracts and commercial
18. Niyomdecha M, Muandao K, Kuttiyod T, Sanongkiet S. products by ultra-performance liquid chromatog-
Α-glucosidase inhibition activities of crude extract and raphy-tandem mass spectrometry. Drug Test Anal.